Items tagged with Drug-resistant TB
Eugene Bell Foundation calls for support to treat more TB patients in North Korea (post)
SEOUL, Aug. 17 -- The head of the Eugene Bell Foundation Korea on Wednesday voiced hope that more tuberculosis patients in North Korea could receive timely medication even at a time of heightened inter-Korean tensions.
Bangladesh introducing cheaper, shorter MDR-TB treatment course in January (post)
Bangladesh is changing the way the world treats the dangerous form of tuberculosis as the country’s own research has received World Health Organisation’s (WHO) approval.
Launch of a new web based pharmacovigilance system called PViMS (post)
The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health, has launched a new, web-based pharmacovigilance management system called PViMS. PViMS enables health programs in low- and middle-income countries to follow recent World Health Organization (WHO) recommendations for implementing active drug safety monitoring and management (aDSM) when introducing new tuberculosis (TB) drugs and novel regimens.
Battling drug-resistant TB, and the Indian government (post)
It is doubtful when he wrote a letter to a medical journal about patients in Mumbai afflicted with an untreatable form of tuberculosis that Dr. Zarir Udwadia was seeking to become the source of controversy himself. But instead of provoking an all-out attack on the disease, as he had hoped, the letter set off a global health alarm and, at least initially, prompted a backlash from the government.
More effective medication for HIV and MDR-TB (post)
Patients with both HIV and multidrug-resistant tuberculosis (MDR-TB) can now receive better-balanced medication. This may shorten the treatment duration for MDR-TB and reduce the many side effects associated with current treatments, such as hearing loss and nausea. It will hopefully also help reduce the development of antibiotic resistance. These are the findings of new research from Uppsala University.
The socioeconomic impact of multidrug-resistant TB on patients: results from Ethiopia, Indonesia and Kazakhstan (post)
Abstract
Fighting antimicrobial resistance globally (post)
Alignment of data requirements by regulators worldwide can contribute to stimulate the development of new antibiotics to fight antimicrobial resistance and protect global public health. However, regulatory activities are only one element of the comprehensive and multifaceted response needed to encourage and accelerate development of new antibacterial medicines that meet patient needs.
4 survivors share stories of living through the horror that is tuberculosis (post)
Tuberculosis (TB ) is one of India’s severest health crises killing over a 1000 Indians every day. Over the last several years, that I have worked on TB I was struck how rarely we hear from those most affected by TB-namely patients and their families. How can the survivors of India’s severest health crisis be faceless and voiceless?
Multidrug-resistant TB cure rates in Europe higher than expected (post)
Cure rates for multidrug-resistant tuberculosis (MDR-TB) in Europe have been estimated to be twice as high as previously thought, according to a research team at Queen Mary University of London (QMUL).
Page 33 of 117 · Total posts: 0
←First 32 33 34 Last→